Awareness campaign | pharmaphorum

Skip to main content

Sunday 22 December 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Awareness campaign

News

Former Welsh rugby union captain Alum Wyn Jones

Welsh rugby great fronts UK atrial fibrillation campaign

Former Welsh rugby union captain Alum Wyn Jones is the face of a new awareness campaign launching in the UK today to draw attention to atrial fibrillation (AF), an irregular and potentially

News

access to rare disease therapies

Clinigen educates on early access to rare disease therapies

On Rare Disease Day, Clinigen has launched a campaign to try to encourage doctors and patients to explore how they can get early access to investigational therapies.

Patients

date on the calendar

World Lung Cancer Day: Why awareness days matter

The 1st August was World Lung Cancer Day.

News

Rare Disease Day

Sanofi sings a song for rare disease and equitable care

'This is Rare' campaign sings the plight of the rare disease community this awareness day.

Views & Analysis

Pituitary gland in 3D view

Calls to end the silent epidemic of PTHP

Campaigners want to raise awareness of post-traumatic hypopituitarism following a head injury.

Editor's Picks

Novo completes $16.5bn takeover of Catalent

UnitedHealth killing suspect gets first-degree murder charge

Novo sets aside $1.2bn for rare diseases plant

Lilly's Alzheimer's drug Kisunla is cleared in China

PBM reform looms in end-of-year US legislation package

News

Patient using a positive airway pressure mask

Lilly grabs first-ever FDA nod for a sleep apnoea drug

Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

The AI effect in pharma commercial strategy: From data to real-time insight & actions

Sponsored

The AI effect in pharma commercial strategy: From data to re...

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company